Purpose of the Test
- Confirming the complete absence of cancer cells post-treatment.
- Evaluating the patient's response to the specific treatment protocol.
- Early prediction of potential relapse before clinical symptoms appear.
Book MRD Testing in Saudi Arabia | Lahalak Medical Platform
MRD testing provides ultra-sensitive detection of residual cancer cells after treatment, enabling oncologists to assess treatment efficacy, predict potential relapses, and personalize follow-up care for optimal patient recovery.
Scientific name: Minimal Residual Disease (MRD) Testing
A highly sensitive laboratory technique used to detect trace amounts of cancer cells remaining after treatment, crucial for monitoring hematologic malignancies and ensuring total eradication of the disease.
Service type
Specialized Laboratory Test
Duration
20-30 minutes
Fasting
Fasting is not required
Included Services
- Sample collection (Blood/Marrow)
- Flow cytometry or Molecular analysis
- Detailed medical report
Medical Service Information
Target Groups
- Patients with various types of Leukemia.
- Patients diagnosed with Multiple Myeloma.
- Patients who have completed chemotherapy or radiation cycles.
Clinical Importance
- Assists in making informed decisions about stopping or modifying treatment.
- Provides sensitivity up to detecting one cancer cell among a million healthy cells.
- Reduces patient anxiety by providing scientific confirmation of recovery status.
Conditions & Notices
- Previous medical reports preferred
- Prior coordination with treating oncologist
Medical services you might also like
